Intractable Self-harm-What Support is Effective?

Condition(s) studied

Investigational drug(s) / intervention(s)

National specialized medical care unit for severe self-harm behaviour-Consultation model: Extensive assessments. Consultation and training for existing treatment providers and caregivers. Network-meetings for providers and caregivers.

Study summary

The aim of this project is to evaluate a novel treatment program for individuals with intractable and lethal self-harm.

The main questions are:

1: Is there, in individuals with intractable self-harm, a relevant improvement in daily functioning and is this improvement related to the provided interventions?

The secondary research questions are:

2\. Is there, in individuals with intractable self-harm, a relevant improvement in frequency and severity of self-harm?

3\. Is there, in individuals with intractable self-harm, a relevant improvement in voluntary hospital admissions?

4\. Is there, in individuals with intractable self-harm, a relevant improvement in compulsary hospital admissions?

5\. Is there, in individuals with intractable self-harm, a relevant improvement in the use of medication pro re nata?

6\. Is there, in individuals with intractable self-harm, a relevant improvement in cost-effectiveness related to the provided interventions?

Eligibility

Primary outcome measure(s)

• The World Health Organization Disability Assessment Schedule II (WHODAS 2.0) — Monthly from baseline to endpointat 24 months and at follow-up at 36 months.
  Level of daily functioning and disability in the domains of cognition, mobility, self-care, getting along with other people and life activities.

Trial sites (1)

More Region Skane trials in Sweden

Other trials for the same condition